Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-21

Clinical Trial Update: Enhancing Social Skills in Schizophrenia Spectrum Disorders - Oxytocin as add-on to Psychosocial Treatment [Phase 2]

View source ↗

Summary

This entry describes a Phase 2 clinical trial evaluating oxytocin as an add-on to psychosocial treatment to enhance social skills in schizophrenia spectrum diso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: Central Institute of Mental Health, Mannheim | Conditions: Schizophrenia Spectrum Disorders (SSD) | Phase 2 | Status: RECRUITING